XOMAO
XOMA Corporation
XOMA Corporation (XOMAO) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 26.2 (oversold), with 0/3 trend checks passing.
XOMAO with MA50 and MA200
Key levels & signals
XOMA Corporation (XOMAO) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $25.00, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 1.2% and below the 200-day moving average by 1.6%.
XOMAO currently has an RSI reading of 26.2, which suggests weaker momentum and a more oversold condition. Some traders may review this kind of setup for a rebound or buy-the-dip idea, but oversold readings by themselves do not guarantee a reversal.
For traders reviewing XOMAO next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About XOMA Corporation
Based in Emeryville, California, and founded in 1981, XOMA Corporation functions as a specialized biotechnology royalty aggregator, with operations spanning Europe, the United States, and the Asia Pacific. The company's core mission is to contribute to advancing human health by empowering other biotechnology firms. XOMA achieves this by purchasing the future economic interests, often in the form of royalties, associated with therapeutic candidates still in their pre-commercial development stages, which have already been licensed to pharmaceutical or biotechnology partners. Their strategic focus is primarily on early to mid-stage clinical assets, specifically those in Phase 1 and 2, that demonstrate significant potential for commercial sales once fully developed by their licensees. Currently, XOMA manages a substantial portfolio comprising approximately 70 such assets.
XOMAO shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about XOMAO
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.